Pharmaceutical

Cue Biopharma downsizes to focus on autoimmune pipeline

The company has fired 25% of its staff and plans to look for partnerships to further its oncology candidates.

Jul 28, 2024 - 04:00
Cue Biopharma downsizes to focus on autoimmune pipeline
The company has fired 25% of its staff and plans to look for partnerships to further its oncology candidates.
Read the original article

Tags:

Previous Article

Inside the efforts to rescue a rare disease gene therapy 

Next Article

Roche records 4% decline in H1 2024 net income

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Listen: Decoding biotech hype, the Sarepta saga, & au revoir to a CEO

Listen: Decoding biotech hype, the Sarepta saga, & au r...

Nov 3, 2023

STAT+: A junior scientist. A prominent oncologist. Now, a clash at MD Anderson over who gets research credit

STAT+: A junior scientist. A prominent oncologist. Now,...

Feb 9, 2024

Quitting alcohol — or even drinking less — reduces risk of oral cavity and esophageal cancer, per new analysis

Quitting alcohol — or even drinking less — reduces risk...

Dec 27, 2023